<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cardiac imaging with computed tomography and magnetic resonance in the adult</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cardiac imaging with computed tomography and magnetic resonance in the adult</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Cardiac imaging with computed tomography and magnetic resonance in the adult</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Udo Hoffmann, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Warren J Manning, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jeroen J Bax, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 13, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cardiac computed tomography (CT) and cardiovascular magnetic resonance (CMR) imaging have emerged as options for noninvasive evaluation of the heart in clinical practice. Coronary CT angiography (CCTA) represents a widely available and well-tolerated examination which visualizes the presence and extent of coronary artery disease (CAD) noninvasively both in the acute and nonacute setting. CMR with morphologic and functional assessment is used to diagnose both ischemic and nonischemic cardiomyopathy, myocarditis, valvular, and pericardial disease. Both cardiac CT and CMR are tomographic imaging technologies.</p><p>The clinical use of CCTA and CMR are described here, including imaging protocols, diagnostic findings, and subsequent management recommendations, as well as risk benefit considerations. Other related topics on cardiac imaging and their clinical use are:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5328.html" rel="external">"Overview of stress radionuclide myocardial perfusion imaging"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5310.html" rel="external">"Overview of stress echocardiography"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1534.html" rel="external">"Stress testing for the diagnosis of obstructive coronary heart disease"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5297.html" rel="external">"Coronary artery calcium scoring (CAC): Overview and clinical utilization"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4948.html" rel="external">"Hypertrophic cardiomyopathy: Clinical manifestations, diagnosis, and evaluation"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4939.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5331.html" rel="external">"Tests to evaluate left ventricular systolic function"</a>.)</p><p></p><p class="headingAnchor" id="H5"><span class="h1">CARDIAC CT</span><span class="headingEndMark"> — </span>Cardiac CT is most often performed as contrast-enhanced coronary CT angiography (CCTA) to evaluate for the presence and extent of CAD. Because of the technical improvements in CT scanner technology, the examination is available at most medical centers, but may not be available at smaller or geographically remote community practice settings.</p><p class="headingAnchor" id="H190580390"><span class="h2">Coronary CT angiography (CCTA)</span></p><p class="headingAnchor" id="H4194395465"><span class="h3">Patient selection for CCTA</span><span class="headingEndMark"> — </span>CCTA is used to detect obstructive CAD in patients with stable angina as well as in patients with acute coronary syndrome.</p><p class="headingAnchor" id="H1080487527"><span class="h4">Stable angina</span></p><p class="headingAnchor" id="H2995440020"><span class="h5">Detection of obstructive CAD</span><span class="headingEndMark"> — </span>Among available noninvasive tests, CCTA has the highest diagnostic accuracy for the detection of obstructive CAD defined as &gt;50 percent luminal narrowing in major epicardial vessels as detected by invasive coronary angiography. Especially because of its high sensitivity and corresponding low rate of false negatives, CCTA is a test best suited to identify patients at low risk for future major adverse cardiovascular events (MACE). The ideal patient for CCTA would have an intermediate pretest probability (10 to 90 percent) for significant CAD (as defined by the Diamond-Forrester score) in whom diagnostic assessment is warranted, but one in whom exclusion of significant CAD is the primary goal of testing.</p><p>Pretest probability instruments in use in contemporary practice, including the Diamond-Forrester score, dramatically overestimate (eg, three- to fivefold) the true prevalence of significant CAD in some populations and may lead to CCTA overutilization. Better clinical risk stratification tools under development aim to improve appropriate utilization of CCTA. Choice of CCTA among alternative tests (eg, stress testing or myocardial single photon emission computed tomography) in this setting is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/1502.html" rel="external">"Selecting the optimal cardiac stress test"</a>.)</p><p class="headingAnchor" id="H2982334859"><span class="h5">Prognostic value of CAD</span><span class="headingEndMark"> — </span>CCTA not only detects the presence and extent of stenosis but also coronary plaque. Overall, the presence and extent of both aspects of CAD are strong predictors for future MACE [<a href="#rid1">1-9</a>]. For example, the absence of any CAD on CCTA carries a warranty period of up to five years for a very low risk (&lt;0.2 percent) of MACE, while the presence of nonobstructive and obstructive CAD carries a three- and sixfold increased risk of future MACE over five years compared with those without these findings. Thus, the test findings can be used to guide subsequent management by diagnosing obstructive CAD for potential revascularization procedures and by assessing prognosis for antiatherosclerotic medical therapy.</p><p class="headingAnchor" id="H3632887004"><span class="h4">Acute coronary syndrome</span><span class="headingEndMark"> — </span>In patients with intermediate or low probability of acute coronary syndrome, early CCTA is an effective test to exclude the diagnosis [<a href="#rid10">10,11</a>]. Absence of CAD on CCTA is associated with an at least two-year period with very low risk of MACE [<a href="#rid12">12</a>]. The choice of CCTA among other management alternatives (eg, stress testing and coronary artery catheterization) in this setting is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/5307.html" rel="external">"Noninvasive testing and imaging for diagnosis in patients at low to intermediate risk for acute coronary syndrome"</a> and  <a class="medical medical_review" href="/d/html/1502.html" rel="external">"Selecting the optimal cardiac stress test"</a>.)</p><p class="headingAnchor" id="H452990537"><span class="h3">CCTA imaging protocol</span><span class="headingEndMark"> — </span>CT scanners with high spatial and temporal resolution are necessary for image acquisition, as imaging is tailored to accurately visualize the presence and extent of CAD, primarily by minimizing motion artifacts. A 64-slice multidetector technology is considered a minimum standard, with more advanced CT scanners (eg, 128-slice, 256-slice, dual source) capable of rendering better images at lower radiation exposure. Image acquisition is synchronized to the electrocardiogram (ECG). A bolus dose of iodinated contrast (typically 50 to 120 mL) is administered intravenously. <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">Nitroglycerin</a>, sublingual tablet or spray, is given immediately prior to the examination to dilate the coronary arteries and facilitate assessment of luminal narrowing. Typically, a short-acting oral or intravenous beta blocker is administered to slow the heart rate to less than 60 to 70 beats per minute.</p><p class="headingAnchor" id="H3825758618"><span class="h3">Contraindications and adverse effects</span><span class="headingEndMark"> — </span>The most common contraindication to CCTA is severe renal insufficiency (ie, estimated glomerular filtration rate test &lt;30 mL/min/1.73 m<sup>2</sup>) or a history of allergy to iodinated contrast, (eg, anaphylaxis). In this situation, alternative tests (eg, stress testing) or preventive measures to minimize the potential adverse effects of iodinated contrast (eg, premedication for contrast allergy, hydration for renal insufficiency) are available. (See  <a class="medical medical_review" href="/d/html/113083.html" rel="external">"Patient evaluation prior to oral or iodinated intravenous contrast for computed tomography"</a>.)</p><p>Patients must be cooperative and able to hold their breath for 5 to 10 seconds. Cardiac tachyarrhythmias (eg, atrial fibrillation) and excessive motion due to inability to perform a breath-hold can lead to nondiagnostic CCTA examinations, especially with basic 64-slice technology [<a href="#rid13">13,14</a>].</p><p>With the development of dose reduction technology and increased spatial and temporal resolution, the newest CT scanner technology enables high-quality diagnostic CCTA acquisition at median effective radiation doses between 2 and 5 mSv, comparable with one to two years of background radiation (which is about 3.1 mSv at sea level) [<a href="#rid15">15,16</a>]. However, the dose can be significantly higher (up to 12 or 15 mSv) using first generation 64-slice CT scanners or in individual patients (eg, obese, high heart rate).</p><p class="headingAnchor" id="H4218215124"><span class="h3">CCTA diagnostic performance and results reporting</span></p><p class="headingAnchor" id="H1581950158"><span class="h4">Diagnostic accuracy</span><span class="headingEndMark"> — </span>CCTA detects luminal narrowing of ≥50 percent diameter with high sensitivity and negative predictive value.</p><p>The diagnostic accuracy of CCTA for detection of ≥50 percent diameter stenoses using invasive coronary angiography as the reference standard has been measured in a number of multicenter studies using scanners from multiple vendors [<a href="#rid1">1-3</a>]. CCTA consistently demonstrates a patient-based sensitivity of 95 to 99 percent. However, the specificity of CCTA is variable, ranging from 64 to 90 percent, and is subject to image quality and underlying artifacts from patient factors. For example, in patients with high calcium scores (ie, &gt;400 Agatston units), a specificity as low as 53 percent has been reported [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H1796398800"><span class="h4">CAD-RADS categories</span><span class="headingEndMark"> — </span>A standardized radiology reporting system for CCTA (CAD-reporting and data system [CAD-RADS]) has been introduced and endorsed by professional societies [<a href="#rid17">17</a>].</p><p>CAD-RADS describes CCTA findings and classifies them according to management recommendations in patients with either acute  (<a class="graphic graphic_table graphicRef120200" href="/d/graphic/120200.html" rel="external">table 1</a>) or stable  (<a class="graphic graphic_table graphicRef120199" href="/d/graphic/120199.html" rel="external">table 2</a>) chest pain.</p><p>CAD-RADS categories are:</p><p class="bulletIndent1"><span class="glyph">●</span>CAD-RADS 0 – 0 percent stenosis</p><p class="bulletIndent1"><span class="glyph">●</span>CAD-RADS 1 – 1 to 24 percent stenosis</p><p class="bulletIndent1"><span class="glyph">●</span>CAD-RADS 2 – 25 to 49 percent stenosis</p><p class="bulletIndent1"><span class="glyph">●</span>CAD-RADS 3 – 50 to 69 percent stenosis</p><p class="bulletIndent1"><span class="glyph">●</span>CAD-RADS 4A – 70 to 99 percent stenosis</p><p class="bulletIndent1"><span class="glyph">●</span>CAD-RADS 4B – &gt;50 percent left main or ≥70 percent three-vessel stenosis</p><p class="bulletIndent1"><span class="glyph">●</span>CAD-RADS 5 – 100 percent stenosis/occlusion</p><p class="bulletIndent1"><span class="glyph">●</span>CAD-RADS N – Nondiagnostic examination</p><p></p><p>Modifiers to each category are sometimes added and include V (vulnerable high-risk plaque), S (stent), or G (graft).</p><p class="headingAnchor" id="H2226949756"><span class="h2">Other cardiac CT applications</span></p><p class="headingAnchor" id="H7"><span class="h3">Left ventricular function and myocardial perfusion</span><span class="headingEndMark"> — </span>Cardiac CT can be performed in the same sitting as CCTA to assess left ventricular morphology, function, and myocardial perfusion, potentially increasing specificity of the examination for CAD [<a href="#rid18">18,19</a>]. CT perfusion requires pharmacological stress and imaging both at rest and with stress. Initial results are promising, but with the availability of alternative tests this examination is limited in use and availability.</p><p class="headingAnchor" id="H1682233221"><span class="h3">Fractional flow reserve</span><span class="headingEndMark"> — </span>CT-based computational fluid dynamics modeling and simulation of fractional flow reserve (FFR) is an emerging technology intended to improve the specificity for CCTA [<a href="#rid20">20,21</a>]. The CT images are segmented to delineate coronary lumen and myocardium, and mathematical models are applied to simulate pharmacological stress across a stenotic segment. This method demonstrates reasonable agreement with FFR measurements derived from coronary artery angiography [<a href="#rid22">22</a>]. FFR-CT is not universally available and is performed only by sending the CT image dataset to a commercial entity that provides the advanced data analysis.</p><p class="headingAnchor" id="H10"><span class="h1">CARDIOVASCULAR MAGNETIC RESONANCE IMAGING</span><span class="headingEndMark"> — </span>CMR is the method of choice for assessment of functional and tissue properties of the heart, including atrial and ventricular anatomy and motion, valvular function, myocardial tissue composition, and pericardial disease. The necessary technology and imaging expertise for CMR are available at major medical centers but are subject to geography and associated clinical expertise. (See  <a class="medical medical_review" href="/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging"</a>.)</p><p class="headingAnchor" id="H1305047843"><span class="h2">Patient selection for CMR</span><span class="headingEndMark"> — </span>Patients evaluated with CMR typically have advanced and more complex diseases, and are usually referred after initial testing with first-line technology (ie, transthoracic echocardiography).</p><p class="headingAnchor" id="H1255858019"><span class="h2">CMR imaging protocol</span><span class="headingEndMark"> — </span>The technical requirements, indications [<a href="#rid23">23,24</a>], imaging protocols [<a href="#rid25">25</a>], and reporting of CMR are increasingly standardized and often tailored to each clinical indication.</p><p>Generally, a 1.5 Tesla (T) or 3 T CMR unit capable of ECG-gated imaging is utilized. Standard four-chamber and short-axis balanced steady-state free precession cine images are usually acquired from the base of the heart to the apex to assess ventricular wall thickness, mass, and regional/global systolic function. Parametric mapping with native (noncontrast) T1, T2, T2*, and/or postgadolinium extracellular volume fraction imaging are commonly performed [<a href="#rid26">26</a>] in the assessment for cardiomyopathies (eg, amyloid, iron deposition). Phase contrast flow imaging is performed orthogonal to the main pulmonary artery and aorta to directly measure right and left ventricular forward flow, respectively. Flow can also be measured directly across the mitral or aortic valve or through any area of interest (eg, atrial septal defect).</p><p>Gadolinium contrast is given if assessment of scar or fibrosis is indicated. Pharmacologic stress perfusion imaging, if indicated and locally available, is performed using either inotropic (eg, <a class="drug drug_general" data-topicid="9380" href="/d/drug information/9380.html" rel="external">dobutamine</a>) or vasodilator (eg, <a class="drug drug_general" data-topicid="9462" href="/d/drug information/9462.html" rel="external">regadenoson</a>, <a class="drug drug_general" data-topicid="9359" href="/d/drug information/9359.html" rel="external">adenosine</a>, or <a class="drug drug_general" data-topicid="9377" href="/d/drug information/9377.html" rel="external">dipyridamole</a>) agents.</p><p class="headingAnchor" id="H909504223"><span class="h2">Contraindications and adverse events</span><span class="headingEndMark"> — </span>Common contraindications to CMR are metallic or electrical implants, devices, or foreign bodies. Most contemporary cardiac implantable electronic devices are MRI-safe (see  <a class="medical medical_review" href="/d/html/113084.html" rel="external">"Patient evaluation for metallic or electrical implants, devices, or foreign bodies before magnetic resonance imaging"</a>). Gadolinium is usually not administered to patients with severe renal insufficiency (ie, estimated glomerular filtration rate &lt;30 mL/min/1.73 m<sup>2</sup>). (See  <a class="medical medical_review" href="/d/html/113082.html" rel="external">"Patient evaluation before gadolinium contrast administration for magnetic resonance imaging"</a>.)</p><p>The table time for image acquisition can be long, and the patient must be able to lie flat in the scanner for 40 to 60 minutes. Irregular heart or breathing rhythms may result in lower image quality and longer scan times.</p><p class="headingAnchor" id="H3529964887"><span class="h2">CMR use by clinical indication</span><span class="headingEndMark"> — </span>CMR enables further evaluation of the myocardium for ischemia (eg, perfusion, viability, scar), inflammation, or infiltration (eg, deposition with iron, amyloid, etc). In addition, CMR is used to further evaluate suspected valvular dysfunction (eg, stenosis, regurgitation), the pericardium, suspected cardiac tumors, and coronary artery anatomy.</p><p class="headingAnchor" id="H499549676"><span class="h3">Myocardial disease</span></p><p class="headingAnchor" id="H113559629"><span class="h4">Stress testing for myocardial ischemia</span><span class="headingEndMark"> — </span>In patients with suspected CAD, CMR is performed both at rest and after pharmacologic stress, to evaluate for ischemia (<a class="drug drug_general" data-topicid="9380" href="/d/drug information/9380.html" rel="external">dobutamine</a>/wall motion or vasodilator/perfusion deficit).The cine motion of the ventricular walls during systole and diastole is visualized and the chambers can be assessed volumetrically. Vasodilator perfusion CMR is performed with first-pass of gadolinium contrast. Stress testing with CMR is described elsewhere. (See  <a class="medical medical_review" href="/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging", section on 'Ischemic heart disease'</a> and  <a class="medical medical_review" href="/d/html/5307.html" rel="external">"Noninvasive testing and imaging for diagnosis in patients at low to intermediate risk for acute coronary syndrome", section on 'Stress CMR'</a>.)</p><p class="headingAnchor" id="H540096810"><span class="h4">Nonischemic cardiomyopathy</span><span class="headingEndMark"> — </span>CMR is the preferred imaging examination as a follow-up to echocardiography in patients with suspected nonischemic cardiomyopathy (eg, infiltrative disease, iron deposition, hypertrophic cardiomyopathy, amyloid, etc) to diagnose the underlying etiology and to assess myocardial viability and function. Native T1, T2, T2*, and extracellular volume fraction assessment is often used. In these patients, ischemic cardiomyopathy has already been excluded. Evaluation of cardiomyopathy with CMR is described elsewhere. (See  <a class="medical medical_review" href="/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging", section on 'Cardiomyopathy'</a> and  <a class="medical medical_review" href="/d/html/5331.html" rel="external">"Tests to evaluate left ventricular systolic function", section on 'Cardiovascular magnetic resonance imaging'</a> and  <a class="medical medical_review" href="/d/html/4948.html" rel="external">"Hypertrophic cardiomyopathy: Clinical manifestations, diagnosis, and evaluation", section on 'Cardiovascular magnetic resonance'</a>.)</p><p class="headingAnchor" id="H1128674491"><span class="h4">Myocarditis</span><span class="headingEndMark"> — </span>Acute myocarditis is a diagnostic consideration in patients with chest pain or heart failure symptoms, elevated troponin level and/or non-coronary ventricular dysfunction on echocardiography, and no clear evidence of underlying cardiac ischemia. CMR often provides supportive evidence of myocarditis when endomyocardial biopsy is not performed. CMR acquisition and reporting for suspected myocarditis is described elsewhere. (See  <a class="medical medical_review" href="/d/html/4939.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in adults"</a> and  <a class="medical medical_review" href="/d/html/4939.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in adults", section on 'Cardiovascular magnetic resonance'</a>.)</p><p class="headingAnchor" id="H3795848673"><span class="h3">Valvular disease</span><span class="headingEndMark"> — </span>Following cardiac echocardiography, CMR enables detailed assessment of valvular motion and enables visualization of flow dynamics for turbulence and quantification of regurgitation. Use of CMR for suspected valvular disease is described elsewhere. (See  <a class="medical medical_review" href="/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging", section on 'Valvular heart disease'</a>.)</p><p class="headingAnchor" id="H1468167324"><span class="h3">Pericardial disease</span><span class="headingEndMark"> — </span>CMR enables direct visualization of the pericardium and is used in suspected underlying pericardial disease such as recurrent pericarditis, thickening/constrictive pericarditis, tumor invasion, and congenital absence of the pericardium. For CMR tagging, spatial modulation of magnetization methods are often used. (See  <a class="medical medical_review" href="/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging", section on 'Pericardial disease'</a>.)</p><p class="headingAnchor" id="H2103837643"><span class="h3">Cardiac tumor</span><span class="headingEndMark"> — </span>CMR is the preferred examination for evaluating suspected cardiac tumors or thrombi detected on echocardiography. CMR enables better characterization of the tissue composition and perfusion, as well as improved detection of intracardiac thrombi. Use of CMR in evaluation of cardiac tumors is described elsewhere. (See  <a class="medical medical_review" href="/d/html/4881.html" rel="external">"Cardiac tumors"</a>.)</p><p class="headingAnchor" id="H3394826541"><span class="h3">Coronary artery disease</span><span class="headingEndMark"> — </span>Noncontrast CMR can be used to identify the coronary artery origins and thus avoid the radiation and iodinated contrast associated with CCTA. In addition, no beta blockers are used for coronary artery CMR. However, if CMR is not available or not feasible (eg, contraindications to CMR), CCTA can also be used, as it yields higher-resolution images and comparable diagnostic performance.</p><p class="headingAnchor" id="H3815047755"><span class="h4">Coronary stenosis</span><span class="headingEndMark"> — </span>Because of limitations in study duration, spatial resolution, and sensitivity to patient motion, CMR is less practical than CCTA for evaluating the coronary arteries. Coronary artery CMR is less accurate than CT in diagnosing clinically significant (≥50 percent) stenoses of the coronary arteries [<a href="#rid27">27,28</a>].</p><p class="headingAnchor" id="H25"><span class="h4">Congenital artery anomalies</span><span class="headingEndMark"> — </span>The risk of sudden cardiac arrest is increased in patients with congenital coronary anomalies when the proximal segment of an anomalous coronary artery courses between the aorta and the pulmonary artery. In this setting, the anomalous vessel may become compressed, leading to myocardial ischemia and possibly fatal arrhythmias. This is most likely to occur during periods of high cardiac output, as in young athletes and military recruits. (See  <a class="medical medical_review" href="/d/html/1536.html" rel="external">"Congenital and pediatric coronary artery abnormalities"</a> and  <a class="medical medical_review" href="/d/html/986.html" rel="external">"Athletes: Overview of sudden cardiac death risk and sport participation"</a>.)</p><p>Whether an anomalous coronary artery follows such a malignant "interarterial course" or whether it courses in a benign fashion in front of the pulmonary artery or behind the aorta can be determined by CCTA [<a href="#rid29">29,30</a>] and by coronary artery CMR with very high accuracy and often much greater ease than by invasive, selective coronary angiography.</p><p class="headingAnchor" id="H26"><span class="h4">Coronary artery aneurysms/Kawasaki disease</span><span class="headingEndMark"> — </span>The vast majority of acquired coronary artery aneurysms are due to Kawasaki disease, a generalized vasculitis occurring in infants and young children. Coronary artery aneurysms occur in 20 to 25 percent of patients with Kawasaki disease who are treated with <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>. In two comparative studies with a total of 19 children, adolescents, and young adults with coronary aneurysms and/or ectasia, CMR was as accurate as conventional invasive coronary angiography in identifying and defining (aneurysm diameter and length) the lesions [<a href="#rid31">31,32</a>]. (See  <a class="medical medical_review" href="/d/html/5772.html" rel="external">"Cardiovascular sequelae of Kawasaki disease: Clinical features and evaluation"</a>.)</p><p class="headingAnchor" id="H1500999265"><span class="h4">Aorta aneurysm, dissection, coarctation</span><span class="headingEndMark"> — </span>Gadolinium contrast and noncontrast CMR angiography are commonly used for the identification, characterization, and monitoring of known or suspected aortic aneurysm or dissection, as well as localization of aortic coarctation. An advantage of CMR versus cardiac CT is the lack of ionizing radiation or potentially harmful iodinated contrast. (See  <a class="medical medical_review" href="/d/html/8190.html" rel="external">"Clinical features and diagnosis of acute aortic dissection", section on 'Cardiovascular imaging'</a> and  <a class="medical medical_review" href="/d/html/8192.html" rel="external">"Clinical manifestations and diagnosis of thoracic aortic aneurysm"</a> and  <a class="medical medical_review" href="/d/html/8192.html" rel="external">"Clinical manifestations and diagnosis of thoracic aortic aneurysm", section on 'Imaging diagnosis'</a> and  <a class="medical medical_review" href="/d/html/87283.html" rel="external">"Overview of abdominal aortic aneurysm"</a> and  <a class="medical medical_review" href="/d/html/87283.html" rel="external">"Overview of abdominal aortic aneurysm", section on 'Imaging'</a> and  <a class="medical medical_review" href="/d/html/7569.html" rel="external">"Screening for abdominal aortic aneurysm"</a>.)</p><p class="headingAnchor" id="H859252185"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/119863.html" rel="external">"Society guideline links: Multimodality cardiovascular imaging appropriate use criteria"</a>.)</p><p class="headingAnchor" id="H38"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac computed tomography (CT) is most often performed as contrast-enhanced coronary CT angiography (CCTA) to evaluate for the presence and extent of coronary artery disease (CAD). Because of the technical improvements in CT scanner technology, the examination is available at most major medical centers but may not be available at smaller or geographically remote community practice settings. (See <a class="local">'Cardiac CT'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Because of its high sensitivity and corresponding low rate of false negatives, CCTA is a test best suited to classify patients with suspected CAD as low risk and to exclude significant disease. CCTA noninvasively detects the presence and extent of CAD, including plaque and stenosis, and is a strong predictor for future major adverse cardiovascular events. (See <a class="local">'Coronary CT angiography (CCTA)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 64-slice multidetector technology is considered a minimum standard, with more advanced CT scanners (eg, 128-, 256-, 320-slice, dual source) capable of rendering better images at lower radiation exposure. Image acquisition is synchronized to the ECG. A bolus dose of iodinated contrast (typically 50 to 120 cc) is administered intravenously. <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">Nitroglycerin</a>, sublingual tablet or spray, is given immediately prior to the examination to dilate the coronary arteries and, often, an oral or intravenous beta blocker is administered to slow the heart rate to less than 60 to 70 beats per minute. (See <a class="local">'CCTA imaging protocol'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A standardized radiology reporting system for CCTA (CAD-reporting and data system [CAD-RADS]) describes CCTA findings and classifies them according to management recommendations in patients with either acute  (<a class="graphic graphic_table graphicRef120200" href="/d/graphic/120200.html" rel="external">table 1</a>) or stable  (<a class="graphic graphic_table graphicRef120199" href="/d/graphic/120199.html" rel="external">table 2</a>) chest pain. (See <a class="local">'CAD-RADS categories'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular magnetic resonance (CMR) imaging is the method of choice for assessment of functional and tissue properties of the heart, including atrial and ventricular anatomy and regional/global systolic function, myocardial tissue composition, valvular disease, pericardial disease, intracardiac masses, and aortic disease. The necessary technology and imaging expertise for CMR are available at most medical centers but are subject to geography and associated clinical expertise. (See <a class="local">'Cardiovascular magnetic resonance imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients evaluated with CMR typically have advanced and more complex diseases, and are referred after initial testing with first-line technology (ie, transthoracic echocardiography). The technical requirements, imaging protocols, and reporting of CMR are becoming standardized, but remain tailored to each clinical indication. (See <a class="local">'Patient selection for CMR'</a> above and <a class="local">'CMR imaging protocol'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CMR enables further evaluation of the myocardium for ischemia (eg, perfusion, viability, scar), inflammation, or infiltration (eg, deposition with iron, amyloid, etc). In addition, CMR is used to further evaluate suspected valvular dysfunction (eg, regurgitation), pericardial disease, suspected cardiac tumors, anomalous coronary disease, and aortic disease. (See <a class="local">'CMR use by clinical indication'</a> above.)</p><p></p><p class="headingAnchor" id="H3012781569"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate acknowledges Thomas Gerber, MD, PhD, FACC, FAHA, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Budoff MJ, Dowe D, Jollis JG, et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol 2008; 52:1724.</a></li><li><a class="nounderline abstract_t">Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med 2008; 359:2324.</a></li><li><a class="nounderline abstract_t">Meijboom WB, Meijs MF, Schuijf JD, et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. J Am Coll Cardiol 2008; 52:2135.</a></li><li><a class="nounderline abstract_t">Hoffmann U, Moselewski F, Nieman K, et al. Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J Am Coll Cardiol 2006; 47:1655.</a></li><li><a class="nounderline abstract_t">Hausleiter J, Meyer T, Hadamitzky M, et al. Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. J Am Coll Cardiol 2006; 48:312.</a></li><li><a class="nounderline abstract_t">Motoyama S, Kondo T, Sarai M, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 2007; 50:319.</a></li><li><a class="nounderline abstract_t">Hoffmann U, Nagurney JT, Moselewski F, et al. Coronary multidetector computed tomography in the assessment of patients with acute chest pain. Circulation 2006; 114:2251.</a></li><li><a class="nounderline abstract_t">Goldstein JA, Gallagher MJ, O'Neill WW, et al. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol 2007; 49:863.</a></li><li><a class="nounderline abstract_t">Henneman MM, Schuijf JD, Pundziute G, et al. Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score. J Am Coll Cardiol 2008; 52:216.</a></li><li><a class="nounderline abstract_t">Rybicki FJ, Udelson JE, Peacock WF, et al. 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. J Am Coll Cardiol 2016; 67:853.</a></li><li><a class="nounderline abstract_t">Hoffmann U, Bamberg F, Chae CU, et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. J Am Coll Cardiol 2009; 53:1642.</a></li><li><a class="nounderline abstract_t">Schlett CL, Banerji D, Siegel E, et al. Prognostic value of CT angiography for major adverse cardiac events in patients with acute chest pain from the emergency department: 2-year outcomes of the ROMICAT trial. JACC Cardiovasc Imaging 2011; 4:481.</a></li><li><a class="nounderline abstract_t">Rybicki FJ, Otero HJ, Steigner ML, et al. Initial evaluation of coronary images from 320-detector row computed tomography. Int J Cardiovasc Imaging 2008; 24:535.</a></li><li><a class="nounderline abstract_t">Dewey M, Zimmermann E, Deissenrieder F, et al. Noninvasive coronary angiography by 320-row computed tomography with lower radiation exposure and maintained diagnostic accuracy: comparison of results with cardiac catheterization in a head-to-head pilot investigation. Circulation 2009; 120:867.</a></li><li><a class="nounderline abstract_t">Fuchs TA, Stehli J, Bull S, et al. Coronary computed tomography angiography with model-based iterative reconstruction using a radiation exposure similar to chest X-ray examination. Eur Heart J 2014; 35:1131.</a></li><li><a class="nounderline abstract_t">Gosling O, Loader R, Venables P, et al. A comparison of radiation doses between state-of-the-art multislice CT coronary angiography with iterative reconstruction, multislice CT coronary angiography with standard filtered back-projection and invasive diagnostic coronary angiography. Heart 2010; 96:922.</a></li><li><a class="nounderline abstract_t">Cury RC, Abbara S, Achenbach S, et al. CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr 2016; 10:269.</a></li><li><a class="nounderline abstract_t">Bamberg F, Becker A, Schwarz F, et al. Detection of hemodynamically significant coronary artery stenosis: incremental diagnostic value of dynamic CT-based myocardial perfusion imaging. Radiology 2011; 260:689.</a></li><li><a class="nounderline abstract_t">Varga-Szemes A, Meinel FG, De Cecco CN, et al. CT myocardial perfusion imaging. AJR Am J Roentgenol 2015; 204:487.</a></li><li><a class="nounderline abstract_t">Gonzalez JA, Lipinski MJ, Flors L, et al. Meta-Analysis of Diagnostic Performance of Coronary Computed Tomography Angiography, Computed Tomography Perfusion, and Computed Tomography-Fractional Flow Reserve in Functional Myocardial Ischemia Assessment Versus Invasive Fractional Flow Reserve. Am J Cardiol 2015; 116:1469.</a></li><li><a class="nounderline abstract_t">Zhuang B, Wang S, Zhao S, Lu M. Computed tomography angiography-derived fractional flow reserve (CT-FFR) for the detection of myocardial ischemia with invasive fractional flow reserve as reference: systematic review and meta-analysis. Eur Radiol 2020; 30:712.</a></li><li><a class="nounderline abstract_t">Agasthi P, Kanmanthareddy A, Khalil C, et al. Comparison of Computed Tomography derived Fractional Flow Reserve to invasive Fractional Flow Reserve in Diagnosis of Functional Coronary Stenosis: A Meta-Analysis. Sci Rep 2018; 8:11535.</a></li><li><a class="nounderline abstract_t">Leiner T, Bogaert J, Friedrich MG, et al. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2020; 22:76.</a></li><li><a class="nounderline abstract_t">Doherty JU, Kort S, Mehran R, et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2019; 73:488.</a></li><li><a class="nounderline abstract_t">Kramer CM, Barkhausen J, Bucciarelli-Ducci C, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson 2020; 22:17.</a></li><li><a class="nounderline abstract_t">Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 2017; 19:75.</a></li><li><a class="nounderline abstract_t">Schuijf JD, Bax JJ, Shaw LJ, et al. Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography. Am Heart J 2006; 151:404.</a></li><li><a class="nounderline abstract_t">Dewey M, Teige F, Schnapauff D, et al. Noninvasive detection of coronary artery stenoses with multislice computed tomography or magnetic resonance imaging. Ann Intern Med 2006; 145:407.</a></li><li><a class="nounderline abstract_t">Ropers D, Moshage W, Daniel WG, et al. Visualization of coronary artery anomalies and their anatomic course by contrast-enhanced electron beam tomography and three-dimensional reconstruction. Am J Cardiol 2001; 87:193.</a></li><li><a class="nounderline abstract_t">Deibler AR, Kuzo RS, Vöhringer M, et al. Imaging of congenital coronary anomalies with multislice computed tomography. Mayo Clin Proc 2004; 79:1017.</a></li><li><a class="nounderline abstract_t">Mavrogeni S, Papadopoulos G, Douskou M, et al. Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol 2004; 43:649.</a></li><li><a class="nounderline abstract_t">Greil GF, Stuber M, Botnar RM, et al. Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease. Circulation 2002; 105:908.</a></li></ol></div><div id="topicVersionRevision">Topic 5308 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19007693" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19038879" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Diagnostic performance of coronary angiography by 64-row CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19095130" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16631006" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16843181" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17659199" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17075011" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Coronary multidetector computed tomography in the assessment of patients with acute chest pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17320744" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18617071" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26809772" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19406338" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21565735" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Prognostic value of CT angiography for major adverse cardiac events in patients with acute chest pain from the emergency department: 2-year outcomes of the ROMICAT trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18368512" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Initial evaluation of coronary images from 320-detector row computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19704093" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Noninvasive coronary angiography by 320-row computed tomography with lower radiation exposure and maintained diagnostic accuracy: comparison of results with cardiac catheterization in a head-to-head pilot investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24553723" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Coronary computed tomography angiography with model-based iterative reconstruction using a radiation exposure similar to chest X-ray examination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20538667" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A comparison of radiation doses between state-of-the-art multislice CT coronary angiography with iterative reconstruction, multislice CT coronary angiography with standard filtered back-projection and invasive diagnostic coronary angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27318587" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21846761" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Detection of hemodynamically significant coronary artery stenosis: incremental diagnostic value of dynamic CT-based myocardial perfusion imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25714277" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : CT myocardial perfusion imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26347004" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Meta-Analysis of Diagnostic Performance of Coronary Computed Tomography Angiography, Computed Tomography Perfusion, and Computed Tomography-Fractional Flow Reserve in Functional Myocardial Ischemia Assessment Versus Invasive Fractional Flow Reserve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31696294" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Computed tomography angiography-derived fractional flow reserve (CT-FFR) for the detection of myocardial ischemia with invasive fractional flow reserve as reference: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30069020" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Comparison of Computed Tomography derived Fractional Flow Reserve to invasive Fractional Flow Reserve in Diagnosis of Functional Coronary Stenosis: A Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33161900" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30630640" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32089132" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28992817" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16442907" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16983128" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Noninvasive detection of coronary artery stenoses with multislice computed tomography or magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11152838" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Visualization of coronary artery anomalies and their anatomic course by contrast-enhanced electron beam tomography and three-dimensional reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15301329" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Imaging of congenital coronary anomalies with multislice computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14975477" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11864916" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
